Adial Pharmaceuticals Announces a Warrant Inducement Transaction for Approximately $2.86 Million in Gross Proceeds

GlobeNewswire
2025.11.26 14:03
portai
I'm PortAI, I can summarize articles.

GLEN ALLEN, Va., Nov. 26, 2025 ( GLOBE NEWSWIRE ) -- Adial Pharmaceuticals, Inc. ( NASDAQ: ADIL ) ( "Adial" or the "Company" ) , a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related disorders, today announced its ...

Source: GlobeNewswire The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
© 2025 Longbridge｜Disclaimer